2020
DOI: 10.1016/j.ejphar.2020.173289
|View full text |Cite
|
Sign up to set email alerts
|

Inosine, an endogenous purine nucleoside, avoids early stages of atherosclerosis development associated to eNOS activation and p38 MAPK/NF-kB inhibition in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 72 publications
0
7
0
1
Order By: Relevance
“…In addition, FAD can significantly increase the expression of short-chain acyl coenzyme A dehydrogenase and inhibit pathomyocardial hypertrophy and fibrosis ( 25 ). Inosine can induce the improvement of endothelium-dependent vasodilation, exhibit antiplatelet properties, activate endothelial nitric oxide synthase (eNOS), and reduce p38MAPK/NF-κB pathway expression in aortic tissue ( 26 ). DHEA and estradiol, which participate in steroid hormone biosynthesis, have been confirmed to affect the cardiovascular system through regulation.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, FAD can significantly increase the expression of short-chain acyl coenzyme A dehydrogenase and inhibit pathomyocardial hypertrophy and fibrosis ( 25 ). Inosine can induce the improvement of endothelium-dependent vasodilation, exhibit antiplatelet properties, activate endothelial nitric oxide synthase (eNOS), and reduce p38MAPK/NF-κB pathway expression in aortic tissue ( 26 ). DHEA and estradiol, which participate in steroid hormone biosynthesis, have been confirmed to affect the cardiovascular system through regulation.…”
Section: Discussionmentioning
confidence: 99%
“…In a hypercholesterolemic rat model, inosine treatment improved endothelium-mediated vasodilatation and antiplatelet function ( Lima et al, 2020 ). A recent study suggested that urinary inosine is inversely associated with coronary heart disease risk in men ( Yoon et al, 2020 ).…”
Section: Inosine and Other Diseasesmentioning
confidence: 99%
“…Antikörper, die entzündliche Zytokine (TNF‑α, IL-1β, IL‑6, IL-17 und IL-12/23) neutralisieren, haben vielversprechende, leider aber auch widersprüchliche Ergebnisse gezeigt und bedürfen daher weiterer Forschung [ 7 ]. Kürzlich wurden die pharmakologischen Eigenschaften von Inosin entdeckt, einem NF-kB-Modulator, der als potenzielles Medikament zur Behandlung von Herz-Kreislauf-Erkrankungen in Betracht gezogen werden könnte [ 28 ].…”
Section: Zukunftsperspektivenunclassified